Bruker's Microbiology & Infection Diagnostic Division Showcases Expanding Portfolio, Innovations Throughout Microbial Identification, Sepsis Diagnostics, Molecular Testing, And NGS Workflows
Benzinga Newsdesk 5 months ago
News
At ASM Microbe 2026, Bruker Corporation's (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis
At ASM Microbe 2026, Bruker Corporation's (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.